Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, your so-called facts have been shown to be incorrect numerous times. The most blatant ones are the false 90% sales decline and the modified Consumer Reports article (Post #4477).
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
Post #9438
You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"
Instead of just a snippit of information, lets take a look at the entire picture.
Sales (total revenue)
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.
For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.
Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k
The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.
All data above is easily available on OTC Markets
Just like the guy who can't say "I love you" to his girlfriend, you can't say "application denied because Sucanon is a drug".
You say "My facts are accurate" but no evidence is presented to support your claim. Remember, I did not post #4477 modifying a CR article and I did not cherry-pick the 90% (actually 83%) sales decline. Only you can defend your own posts.
Looking for some beef, but so far we get all bun.
Well, your so-called facts have been shown to be incorrect numerous times. The most blatant ones are the false 90% sales decline and the modified Consumer Reports article (Post #4477).
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
Post #9438
You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"
Instead of just a snippit of information, lets take a look at the entire picture.
Sales (total revenue)
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.
For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.
Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k
The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.
All data above is easily available on OTC Markets.
Again, this is general warnings and nothing in here applies to Roth.
Your post is in itself inaccurate in several ways:
1) These are general warnings from some undisclosed source. A link would be nice. I don't believe this post was composed by the poster.
2) You state "Misleading information:", but again there are no specifics. No examples of the so called "misleading information" are provided.
3) You state as an example of ridiculous potential "a cure for that major disease — could change the world", but I must point out that nobody ever claimed that Sucanon was a "cure" for diabetes. Anyone who knows about diabetes know that medications such as Sucanon helps to manage the disease by reducing blood sugar levels, and diet and exercise are always used in conjunction with the medication.
4) Just saying "FDA denial" is meaningless as the complete full story has been posted by me numerous times, but the fact is that the FDA did not approve an appliation for over the counter sales and did not deny Sucanon because Sucanon is a drug!
5) A web site not operating is hardly breaking news and is hardly a basis for fraud or scam.
You say "wrong...again", but I addressed the fact that your post did not contain a link (it does not contain a link) so am I worng?
You say "wrong...again", but I addressed the fact that your post had warnings that are general and from an undisclosed source. Am I wrong about this?
You say "wrong...again", but I addressed the fact that your post
has no specifics. No examples of the so called "misleading information" are provided.
You say "wrong...again", but I addressed the fact that your post
states an example of ridiculous potential "a cure for that major disease — could change the world", but I must point out that nobody ever claimed that Sucanon was a "cure" for diabetes. Anyone who knows about diabetes know that medications such as Sucanon helps to manage the disease by reducing blood sugar levels, and diet and exercise are always used in conjunction with the medication.
So, please tell me EXACTLY where I am "wrong again"....everyone really wants to know.
Your post is in itself mealeading in several ways:
1) These are general warnings from some undisclosed source. A link would be nice. I don't believe this post was composed by the poster.
2) You state "Misleading information:", but again there are no specifics. No examples of the so called "misleading information" are provided.
3) You state as an example of ridiculous potential "a cure for that major disease — could change the world", but I must point out that nobody ever claimed that Sucanon was a "cure" for diabetes. Anyone who knows about diabetes know that medications such as Sucanon helps to manage the disease by reducing blood sugar levels, and diet and exercise are always used in conjunction with the medication.
As for Consumer Reports post #4477, it is a piece of, shall we say, 'misinformation' and all the buffing and waxing in the world will not change it into gold or silver. It will only be a shiny piece of said 'misinformation'.
I guarantee that nobody has forgotten the modified Consumer Reports article (post #4477). This alone speaks volumes.
All board readers should consider the source of the information presented here on this message board.
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"
Instead of just a snippit of information, lets take a look at the entire picture.
Sales (total revenue)
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.
For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.
Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k
The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.
All data above is easily available on OTC Markets
You say "I stand my my FACT driven posts", but how is it possible to have fact-driven posts without facts?
Prime no-fact posts:
4477 modified CR article
purported 90% sales decline
There are too many no-fact posts to keep track of.
You say "THOSE ARE HORRIBLE disastrous numbers" and your description of the numbers are in relative terms, but the fact remains that your post distorted the facts.
So, if item 7 is so blatently false, and post #4477 is a modified Consumer Reports article that falsely implicates Roth and Sucanon, why should any level of credibility be given to the other 12 items?
Everyone should always consider the source of information especially in light of past lack of transparency.
As I pointed out a few days ago, these are all provably false with the exeception of number 13 which is partly true in that the 120 sq meters is correct.
Number 7 was discussed in great detail a while back. Here is the analysis again:
You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"
Instead of just a snippit of information, lets take a look at the entire picture.
Sales (total revenue)
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.
For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.
Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k
The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.
All data above is easily available on OTC Markets
All of these are false as we both know.
wow!...6,000 posts ago. Post #4477 really is quite infamous.
There is no statue of limitations on modifying and posting Consumer Reports articles.
What is outrageous is post #4477. This should be required reading for everyone. I wonder what Consumer Reports would say if they knew their articles were being modified and posted here?
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
Welcome zikey107.
There are 2 big news items everyone is waiting to break. First is approval of Sucanon by the Indian government for sale in India. Second is results of clinical trials completed at ABC Hospital in Mexico City. This trial compares Sucanon and Metformin head to head.
Always consider the source of information.
Eating Lilac plants can kill you too and Metform is based on this plant. I am not saying Metformin is bad, just that your post is bad logic.
This is a whopper if I ever heard one!
The truth is that the FDA did not ban Sucanon. The did deny an application for over-the-counter sales only because it is a drug. The FDA invited Roth to apply for drug approval, so this does not sould like a ban to me. Think about it.
Too much of anything is harmful. Metformin is based on the Lilac plant.
https://healthunlocked.com/cllsupport/posts/134271197/metformin-the-diabetes-drug-developed-from-french-lilac
Metformin is very hard on the kidneys and for this reason and others is not a good choice for many diabetics.
sweetlou, I would add that not only is the information unattributed and the conclusions incorrect, without a link to the information source nobody can tell if any key sentences are removed to change the entire meaning of the article.
We all remember post 4477 where a key sentence in a Consumer Reports article was deleted to falsely implicate Sucanon. This could be the sequel.
This same false information is posted over and over, so I have to belive that the response are not even being read by poster Jayyy.
So, I will try arain. FDA did not deny Sucanon, but only an application for over the counter sales BECAUSE it is a drug.
The Compliance department of the FDA is the group that would handle an application for drug approval. Contacting Compliance is not a requirement, but is optional for Roth if they wish to apply for approval as a drug. As stated many times before, Roth has made a business decision not to apply for FDA drug approval at this time due to time and cash restraints, but instead is focusing on sales in countries where the FDA has no jurisdiction such as Canada and Mexico where Sucanon is already approved, and hopefully very soon India.
Your claims are just red herrings.
You say "Forget Consumer Reports..." as if to say "there is nothing to see here folks, move on, just keep walking..."
13 is partially true (120 sq meter office).
Al the others are false or misleading at best.
All readers are encouraged to consider the credibility of the information source. Remember, this is the same source that brought us post #4477 where a Consumer Reports article was modified to falsely implicate Roth and Sucanon.
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
You should know that no organization has everything on their website.
The annnouncement is provably not phony. Roth did a press release and ABC hospital has seen the press release. Now, think logically about this. If the news release was phony then surely there would be a follow-up news release by the hospital stating that there is no such clinical study, but this did not happen did it?
No Jayyy, there is nothing phony here.
If what you claim is true, then why the need to delete the key sentence? Why not let all the board readers see the entire article and decide for themselves if it is applicable?
Of course we both know the answer.....the article is not appicable!
Whne this happens it will be like the "Emperor without any clothes", but in this case we will all just laugh and let him stand there foolishly.
If the CR article is irrelevant, then why was a modified version posted by you originally in post #4477?
I agree that the CR article does not apply to Roth or Sucanon, but the modified version makes it look as though it does.
Why is the key sentence identifying the offending products and companies (Roth/Sucanon are not on the list) removed each time it is posted by you? Why not just post the entire article?
Modifying a Consumer Reports article is indefensible.
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
I imagine there will be claims of false news release and there will be demands to see the signed contract.
You say "No, irrelevant". So post 4477 which modified a Consumer Reports article to defame Roth and sucanon is irrelevant??
Certainly not!
But let us not forget that your post 4477 modified a Consumer Reports article.
Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.
Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM
If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty
21k in the last quarter, but 124k in the previous quarter. Since orders are placed and received in large quantities they can fall into one quarter or the next and this is by chance.
If say a 50k order that just made it into the previous quarter were received a few day later then the quarterly sales would be as follows:
21k + 50k = 71k (previous quarter)
124k - 50k = 74k (latest quarter)
So, I suggest to not get too excited about any one quarter.
As for your statement "Thats INSOLVENT to me", your definition does not matter but the general accepted accounting practices do.
Again, evil sounding words are tossed about and they are not applicable. The FDA denied nothing and certainly Roth is not insolvent.
According to the dictionary, insolvent means "unable to pay debts owed". As of now Roth is paying all its bills.
You are worse than DJT! You say "Sales for Mexico are down almost 90% --FACT" and repeat it over and over even though you know it is incorrect. Facts are meaningless to you.
Here is the real financial information:
You will notice in the data below, at no point, either year over year, or quarter over quarter, has the sales declined 90%. The worst decline is 83% from 124k to 21k in the most recent quarter.
Here is the calculation:
(124-21)/124 = 0.83 or 83% decline
This is not 90%, so this begs the question of where the 90% came from. I suspect it was just free-flowing from some body orifice.
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Nope!......not denied by the FDA at all. The FDA was impressed enough to classify Sucanon as a drug.